Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients

NCT00309478 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1099

Enrollment

NETWORK

Sponsor class

Conditions

Early-stage Breast Cancer

Interventions

DRUG: Cyclophosphamide
DRUG: Methotrexate
DRUG: Fluorouracil implant
DRUG: Goserelin
DRUG: Tamoxifen

Sponsor

Austrian Breast & Colorectal Cancer Study Group

Collaborators

[object Object]